Industry: Global GCPs, Final Rule Should Precede FDA Foreign Study Guidance
This article was originally published in The Gray Sheet
Executive Summary
Medical device makers are concerned about a lack of globally harmonized standards for good clinical practices, which they say could cause problems for a guidance FDA has drafted on studies conducted outside the U.S.